ICUI — ICU Medical, Inc.

ICU Medical, Inc. (ICUI) 是一家 Medical - Instruments & Supplies 公司，屬於醫療保健產業, 目前交易價格為 $127.85. 其SharesGrow評分為 44/100, 表明一般的投資特徵， 7項中通過1項.

SharesGrow calculates the intrinsic value of ICUI = $462.61 (+261.8% 相對於當前價格, 該股票看起來被低估). 分析師共識目標價為 ICUI = $179 (+40% 上漲空間).

估值: ICUI 本益比(P/E)為 4121.4 (S&P 500平均約25) 前瞻PEG為 285.46.

財務數據: 營收為 $2.2B, -0.6%/yr 平均成長. 淨利潤為 $732,000, 成長率為 -45.4%/yr. 淨利潤率為 0% (較薄). 毛利率為 36.8% (+6.2 pp 趨勢).

資產負債表: 總債務為 $1.4B 對比 $2.1B 股東權益 (D/E比率 0.66, 適度). 流動比率為 2.36 (流動性強). 資產負債率為 34.4%. 總資產: $4.1B.

分析師展望: 9 / 11 位分析師評級 ICUI 為買入 (82%) — 強烈共識.

SharesGrow 7項標準細分: Value 31/100 (Fail), Growth 15/100 (Fail), Past 25/100 (Fail), Health 50/100 (Partial), Moat 60/100 (Partial), Future 94/100 (Pass), Income 30/100 (Fail).

$179.00

▲ 40.01% 上漲空間

Average Price Target

基於 11 位華爾街分析師對 ICU Medical, Inc. 提供的12個月價格目標，平均目標價為 $179.00，最高預測為 $180.00，最低預測為 $178.00。

Highest Price Target

$180.00

Average Price Target

$179.00

Lowest Price Target

$178.00

ICUI SharesGrow 評分概覽

44/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

價值 31/100

估值 — P/E, PEG, Forward PEG

成長 15/100

財務數據 — 平均成長

過去 25/100

強勁 — 趨勢

健康 50/100

資產負債表 — D/E比率, 流動比率為

護城河 60/100

毛利率為 + market cap

未來 94/100

分析師展望 — 為買入

收入 30/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — ICUI

✗

價值 Fail

31/100

ICUI 本益比(P/E)為 4121.4 (S&P 500平均約25). Forward PEG 285.46 — 被高估. Trailing PEG 38.72. 分析師共識目標價為 $179, 意味著 +40% 相對於當前價格 $128. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

ICUI: -0.6%/yr 營收為, -45.4%/yr 淨利潤為平均成長. 較弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

ICUI: 1 / 4 年獲利. 較弱. Score = 1 / 4 × 100. ≥ 80 = Pass.

資產負債表 ICUI: D/E比率 0.66 (適度), 流動比率為 2.36 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

ICUI: 毛利率為 36.8% (+6.2 pp 趨勢), $3B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 60/100. ≥ 70 = Pass.

分析師展望: 9 / 11 位分析師評級 ICUI 為買入 (82%). 分析師共識目標價為 $179 (+40% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

ICUI: 淨利潤率為 0%. 較薄 (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間107-160.29

成交量159.37K

30日平均成交量289.7K

市值$3.16B

Beta（1年）0.81

Share Statistics

EPS（TTM）0.03

流通股數$24.64M

IPO Date1992-03-31

Employees15,000

CEOVivek Jain

Financial Highlights & Ratios

Revenue (TTM)$2.23B

Gross Profit$819.66M

EBITDA$326.54M

Net Income$732K

Operating Income$106.95M

Total Cash$307.96M

Total Debt$1.39B

Net Debt$1.08B

Total Assets$4.05B

Price / Earnings (P/E)4304.7

Price / Sales (P/S)1.42

Analyst Forecast

1Y Price Target$179.00

Target High$180.00

Target Low$178.00

上漲空間+40.0%

評級共識Buy

覆蓋分析師數11

買入 82% 持有 18% 賣出 0%

Price Target Summary

公司資訊

國家US

交易所NASDAQ Global Select

貨幣USD

ISINUS44930G1076

股價走勢

ICUI

ICU Medical, Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Instruments & Supplies

107.00 52WK RANGE 160.29

其他人也在看

The Cooper Companies, Inc.

Envista Holdings Corp

$27.38

+1.75%

MMSI

Merit Medical Systems, Inc.

$70.54

-0.04%

HAE

Haemonetics Corporation

ICU Medical, Inc. ICUI NASDAQ

ICUI SharesGrow 評分概覽

評分明細 — ICUI

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒